CYTK vs TER · rev $88.0M vs P/E 76, rev $2.82B
Cytokinetics Inc (CYTK) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
CYTK currently screens at market cap $4.05B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the CYTK and TER stock pages for the full models.
Not investment advice.